1. Home
  2. PCRX vs DAKT Comparison

PCRX vs DAKT Comparison

Compare PCRX & DAKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$23.78

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Daktronics Inc.

DAKT

Daktronics Inc.

HOLD

Current Price

$19.23

Market Cap

1.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCRX
DAKT
Founded
2006
1968
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Office Equipment/Supplies/Services
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
2010
1996

Fundamental Metrics

Financial Performance
Metric
PCRX
DAKT
Price
$23.78
$19.23
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$30.25
N/A
AVG Volume (30 Days)
518.7K
409.2K
Earning Date
05-07-2026
03-04-2026
Dividend Yield
N/A
N/A
EPS Growth
107.44
N/A
EPS
0.16
0.75
Revenue
$541,533,000.00
$608,932,000.00
Revenue This Year
$6.78
$12.94
Revenue Next Year
$8.54
$8.32
P/E Ratio
$150.19
$26.49
Revenue Growth
26.04
6.89
52 Week Low
$18.80
$11.97
52 Week High
$27.99
$28.27

Technical Indicators

Market Signals
Indicator
PCRX
DAKT
Relative Strength Index (RSI) 57.59 37.72
Support Level $23.74 $18.64
Resistance Level $23.94 $19.38
Average True Range (ATR) 0.73 0.75
MACD 0.11 0.12
Stochastic Oscillator 75.36 8.64

Price Performance

Historical Comparison
PCRX
DAKT

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About DAKT Daktronics Inc.

Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.

Share on Social Networks: